As Congress finalizes a sweeping new federal spending bill, healthcare providers are sounding the alarm over what could be at ...

The Trump administration’s budget proposal sends a dangerous message: that the lives and health of people living with HIV are ...

National Aids Commission (NAC) and health campaigners have welcomed the approval of a twice-a-year HIV prevention injection ...

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to diagnose and treat HIV.

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Oil prices jumped on Monday to their highest since January as the United States' weekend move to join Israel in attacking ...

Newsday Zimbabwe She was speaking in an interview on the sidelines of the ongoing Sadc Joint Meeting of Ministers Responsible for Education in Harare yesterday. THE University of Zimbabwe Clinical ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.